Thermo Fisher Scientific ... (TMO)
NYSE: TMO
· Real-Time Price · USD
489.05
4.01 (0.83%)
At close: Aug 15, 2025, 9:57 AM
Thermo Fisher Scientific Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 28, 2025 | Mar 29, 2025 | Dec 31, 2024 | Sep 28, 2024 | Jun 29, 2024 | Mar 30, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jul 1, 2023 | Apr 1, 2023 | Dec 31, 2022 | Oct 1, 2022 | Jul 2, 2022 | Apr 2, 2022 | Dec 31, 2021 | Oct 2, 2021 | Jul 3, 2021 | Apr 3, 2021 |
Revenue | 10.86B | 10.36B | 11.39B | 10.6B | 10.54B | 10.35B | 10.89B | 10.57B | 10.69B | 10.71B | 11.45B | 10.68B | 10.97B | 11.82B | 10.7B | 9.33B | 9.27B | 9.91B |
Cost of Revenue | 6.81B | 6.12B | 6.93B | 6.25B | 6.2B | 6.13B | 6.93B | 6.24B | 6.42B | 6.53B | 7.29B | 6.36B | 6.38B | 6.33B | 5.77B | 4.69B | 4.74B | 4.7B |
Gross Profit | 4.05B | 4.25B | 4.47B | 4.34B | 4.34B | 4.22B | 3.95B | 4.33B | 4.27B | 4.18B | 4.16B | 4.32B | 4.59B | 5.48B | 4.93B | 4.64B | 4.54B | 5.21B |
Operating Income | 1.92B | 1.84B | 2.27B | 1.92B | 1.76B | 1.72B | 1.99B | 1.97B | 1.78B | 1.7B | 1.99B | 1.76B | 1.94B | 2.84B | 2.68B | 2.35B | 2.25B | 3.08B |
Interest Income | 297M | 203M | 227M | 277M | 295M | 279M | 309M | 246M | 178M | 146M | 150M | 68M | 36M | 18M | 11M | 9M | 11M | 12M |
Pretax Income | 1.71B | 1.61B | 1.97B | 1.73B | 1.68B | 1.61B | 1.74B | 1.75B | 1.41B | 1.34B | 1.75B | 1.53B | 1.87B | 2.52B | 1.86B | 2.17B | 2.05B | 2.75B |
Net Income | 1.62B | 1.51B | 1.83B | 1.63B | 1.55B | 1.33B | 1.63B | 1.72B | 1.36B | 1.29B | 1.58B | 1.5B | 1.66B | 2.21B | 1.66B | 1.9B | 1.83B | 2.34B |
Selling & General & Admin | 1.78B | 2.06B | 1.82B | 2.08B | 2.25B | 2.17B | 1.64B | 2.04B | 2.14B | 2.13B | 1.78B | 2.21B | 2.28B | 2.28B | 1.86B | 1.95B | 1.94B | 1.81B |
Research & Development | 352M | 342M | 374M | 346M | 339M | 331M | 327M | 319M | 345M | 346M | 391M | 351M | 365M | 364M | 392M | 351M | 343M | 320M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 2.13B | 2.4B | 2.2B | 2.43B | 2.59B | 2.5B | 1.96B | 2.36B | 2.49B | 2.48B | 2.17B | 2.56B | 2.65B | 2.64B | 2.25B | 2.3B | 2.28B | 2.13B |
Interest Expense | 404M | 303M | 384M | 424M | 421M | 363M | 444M | 393M | 326M | 300M | 269M | 173M | 148M | 136M | 161M | 128M | 122M | 125M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 8.94B | 8.52B | 9.13B | 8.68B | 8.78B | 8.63B | 8.89B | 8.6B | 8.91B | 9.01B | 9.46B | 8.92B | 9.03B | 8.98B | 8.02B | 6.98B | 7.02B | 6.83B |
Income Tax Expense | 92M | 95M | 150M | 99M | 128M | 281M | 133M | 53M | 52M | 46M | 173M | 31M | 198M | 301M | 202M | 271M | 219M | 416M |
Shares Outstanding (Basic) | 378M | 378M | 382.85M | 382M | 382M | 382M | 387M | 386M | 386M | 386M | 391M | 392M | 392M | 392M | 394M | 394M | 393M | 394M |
Shares Outstanding (Diluted) | 378M | 379M | 383M | 384M | 383M | 384M | 388M | 388M | 388M | 388M | 393M | 395M | 394M | 395M | 398M | 397M | 396M | 397M |
EPS (Basic) | 4.28 | 3.99 | 4.79 | 4.27 | 4.05 | 3.48 | 4.21 | 4.44 | 3.53 | 3.34 | 4.03 | 3.81 | 4.24 | 5.65 | 4.20 | 4.83 | 4.65 | 5.93 |
EPS (Diluted) | 4.28 | 3.98 | 4.78 | 4.24 | 4.04 | 3.46 | 4.20 | 4.42 | 3.51 | 3.32 | 4.01 | 3.78 | 4.22 | 5.61 | 4.17 | 4.79 | 4.61 | 5.88 |
EBITDA | 2.8B | 2.63B | 3.07B | 2.91B | 2.98B | 2.79B | 3.02B | 3.01B | 2.61B | 2.52B | 2.89B | 2.61B | 2.9B | 3.54B | 2.71B | 2.93B | 2.83B | 3.5B |
EBIT | 2.11B | 1.92B | 2.33B | 2.17B | 2.19B | 1.95B | 2.18B | 2.16B | 1.76B | 1.66B | 2.05B | 1.77B | 2.06B | 2.68B | 2.02B | 2.3B | 2.17B | 2.88B |
Depreciation & Amortization | 685M | 705M | 742M | 740M | 790M | 836M | 839M | 853M | 855M | 859M | 848M | 838M | 836M | 859M | 683M | 628M | 660M | 621M |